Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
David G. Kiely, Robin Condliffe
Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Airway diseases, Pulmonary vascular diseases
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David G. Kiely, Robin Condliffe. Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow. Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Debate – Controversies in interstitial lung disease
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
PP219 – Development and Validation of a Novel Prognostic Nomogram for COPD patients with Pulmonary Hypertension